A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine.
PHASE1CompletedINTERVENTIONAL
Enrollment
16
Participants
Timeline
Start Date
November 30, 2011
Primary Completion Date
April 30, 2012
Study Completion Date
April 30, 2012
Conditions
Type 2 Diabetics, Chronic Kidney Disease, Protein in Urine
NCT01464320 - A Study to Evaluate the Safety and Tolerability of ABT-614 and Its Effect on Kidney Function in Subjects With Type 2 Diabetes and Chronic Kidney Disease With Protein in Their Urine. | Biotech Hunter | Biotech Hunter